Taken together, this study provided consistent evidence from multi‐omics layers of data that strongly support PSRC1 gene as a potential drug target at medium HDL and with therapeutic potential for CAD, as well as mechanistic clues in terms of its downstream proteins underlying such therapeutic potential. This evidence concerns the gene PSRC1 and coronary artery disorder.